Cardinal Health Net Cash Flow 2010-2025 | CAH

Cardinal Health annual/quarterly net cash flow history and growth rate from 2010 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
  • Cardinal Health net cash flow for the quarter ending March 31, 2025 was $-1.807B, a 447.58% increase year-over-year.
  • Cardinal Health net cash flow for the twelve months ending March 31, 2025 was $-4.339B, a 534.36% increase year-over-year.
  • Cardinal Health annual net cash flow for 2024 was $1.057B, a 258% decline from 2023.
  • Cardinal Health annual net cash flow for 2023 was $-0.669B, a 149.08% decline from 2022.
  • Cardinal Health annual net cash flow for 2022 was $1.363B, a 114.31% increase from 2021.
Cardinal Health Annual Net Cash Flow
(Millions of US $)
2024 $1,057
2023 $-669
2022 $1,363
2021 $636
2020 $240
2019 $768
2018 $-5,116
2017 $4,523
2016 $-2,260
2015 $1,751
2014 $964
2013 $-373
2012 $345
2011 $-826
2010 $1,534
2009 $413
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $36.267B $226.827B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.424B 21.35
Becton Dickinson (BDX) United States $49.374B 12.23
Straumann Holding AG (SAUHY) Switzerland $21.415B 0.00
Labcorp (LH) United States $20.613B 16.72
Cooper (COO) United States $16.288B 21.60
West Pharmaceutical Services (WST) United States $15.136B 31.73
Align Technology (ALGN) United States $13.534B 26.87
Henry Schein (HSIC) United States $8.708B 14.94
Merit Medical Systems (MMSI) United States $5.766B 27.88
DENTSPLY SIRONA (XRAY) United States $3.288B 9.82
CONMED (CNMD) United States $1.847B 13.82
STAAR Surgical (STAA) United States $0.906B 0.00
Lifevantage (LFVN) United States $0.159B 16.38
Pro-Dex (PDEX) United States $0.141B 15.40